Its year-end result. Magnus. Good morning. Also from me, and welcome to this year end presentation. I will also, of course, address the announced rights issue this morning.
But first, I would like to highlight, 2025 has been a transformative year for us. I would like to describe it as a year of deleveraging and profitability measures taken. I would say that we have navigated a complex macroeconomic environment by focusing on what we can control, which is, at the end of the day, cash flow margins and capital structure. And today, we are laying out the roadmap for how Fasadgruppen will lead the market recovery for 2026 and beyond. With that said, I'd like to dive into the presentation.
So first of all, the highlights. Looking at the fourth quarter, I would say that the headline here is resilience delivered a 5.1% organic growth, which I would say is a testament to the underlying demand for our services. Despite the broader construction slowdown, which has been ongoing for some time now. On an Adjusted EBITA level, excluding the divested Alnova business, we came in around 110 million, yielding a margin of 7.6%. This is more indicative of the true earnings power of our core business today.
But even including Alnova, the margin improved year over year up to 7% compared to 6.4% a year ago.
The operating cash flow stood out here at a record 240 million. And this also meant that we brought leverage down to 3.25 in Q4. Before the rights issue, this 3.25 is down from 3.76 in Q3. For those of you who remember that. And, of course, we still see the demand is good. I would say that with this order backlog development of 4.2% organic growth, we prove that we are still in favor, reflecting strong demand in general. I'll get back to that where we see the best demand.
And if we take a look on England. Just a quick glance here before we dive into that later, we still see delays from the Building Safety Regulator. And that is affecting our subsidiary, Clear Line. Then this morning, as I mentioned, we announced a fully guaranteed rights issue. In order to bring down our leverage here down to 2.5 times, in line with our long-term target. And this ensures that we have the dry powder needed for our next growth phase. But I will get back to that.
Next, please.
Then first I would like to comment here. Just some words about the markets.
The interest rate cuts that have been done in 2025 have provided much relief to especially Swedish tenant owner associations. And these interest rate cuts are also expected to improve investments going forward.
There is deferred maintenance in the buildings, but we also see energy efficiency improvements. The European Performance of Buildings Directive, which is called EPBD, is due to be implemented here by local law in all EU countries on the 29th of May, 2026.
To comment on this. In short, the European Union has a strategy to at least double the annual energy renovation rate, meaning that we could be a sweet spot here for many coming years.
Regarding our net sales, we saw a total increase by 6%.
And as I mentioned, 5.1% was organic growth, highlighting that our regions Sweden, Denmark, and especially Finland, all achieved double-digit growth.
On the Norwegian side. We still see some weaker markets in Norway that have been affecting us throughout 2025. And here we are selective about the projects we take on to protect our margins in the UK.
Then, as I mentioned earlier, we still saw BSR delays. But as we announced here in December, we've gotten some more approvals from BSR, meaning that there is potential for further approvals during 2026. Remember, Clear Line has a very strong backlog, and we are looking towards 2028 or so for Clear Line projects now. Then looking at our segments, the Total Solutions segment grew roughly 10%.
Which shows that customers value our full service offering there. And on the Specialist Solutions, we also saw a healthy growth of roughly 6%. Then, of course, Clear Line here was affected, as I mentioned, by BSR, which took down the sales here.
Remember also in the period of 2024, which is the number in brackets here, 126.2, Clear Line was only part of Fasadgruppen for two months.
Next, please. Then, on the profitability side, our internal measures are showing up. As mentioned, the Adjusted EBITA came in at roughly 110.
A margin of 7.6%, which is, I would say in this environment, a strong figure on the Total Solutions side, we saw a small decrease in margin here, but roughly on the same adjusted EBITA level as last year. But what stands out here, of course, is the Specialist Solutions that improved quite significantly compared to last year. The Adjusted EBITA came in at roughly 54 million compared to 8 million last year. Then this meant a margin of more than 10% compared to just 1.6% a year ago. So this is the true hero here in the quarter, I would say.
But mainly this reflects better product execution and more favorable mix, I would say. And of course, as the market recovers, the Specialist Solutions segment is more agile, has shorter projects than the Total Solutions. And that means that when the demand is there, we are also ready to improve the margins quite rapidly in that sense. Then, looking at Clear Line, performance, of course, came in lower than anticipated, which was also affected by the BSR delays. However, the 27% margin here is not what we expected, but it's still not bad.
On the total adjustment side, we have large adjustments of 118 million.
Of which 99.4 million is related to the divestment of Alnova, and we can shift to the next slide so I can show you more. So this is the waterfall then from the reported EBITA up to the adjusted EBITA and also then the adjusted EBITA if you exclude the Alnova.
So in this instance, of course, with the divestment, we took a realization loss which amounted to 99.4 million. We also had some contingent considerations that affected us by 15 million, and we had some acquisition-related costs of roughly 3 million. All in all, you could also mention here that, of course, Alnova made a loss here in two months of roughly 8 million. So that's why we end up at roughly 110 on the adjusted side there. A margin of 7.6%, which is, I would say, in this environment, a strong figure on the Total Solutions side. We saw a small decrease in margin here, but roughly on the same adjusted EBITA level as last year. A margin of 7.6%, which is, I would say, a strong figure in this environment on the Total Solutions side; we saw a small decrease in margin here, but roughly on the same adjusted EBITA level as last year. Then, on the order backlog side, we ended the year at 3.8 billion. And of course, a significant part of that is Clear Line, who has been building backlog. But I would say that this is important. The 1.3 billion roughly that Clear Line has is ready when we get the BSR approvals. And as I mentioned, we are more looking into 2028 for Clear Line now.
I would also like to mention that usually we see a pattern where the order backlog builds up in the first half of the year and then we execute on the second half of the year. And you can see that pattern somewhat in the bars at the bottom right corner. And I would say that this is not anything unusual, but rather how the market works for us. Then, if we take a look at the Swedish entities, we've seen an organic order backlog growth now for the fourth consecutive quarter, which is, of course, a very strong sign. Remember, I would say already in 2023, we saw effects of the Swedish markets struggling. And, looking at the Total Solutions side, it is somewhat lower compared to last year.
But remember, here we had a very large order in Copenhagen that affected the numbers last year. So if you exclude them.
We are also on par on the Total Solutions side. Then you see the Specialist Solutions order backlog is quite stable, and then Clear Line has already commented on, so we can take the next slide please.
On the cash flow side, we saw a record strong operating cash flow here in Q4. 240.5 million. You compare that to last year, which came in at roughly 185 million. So it's a 30% increase, even though roughly the same subsidiaries are still included, and I would say that this cash flow has been an optimization for a long time, and we have improved on our stakeholder terms.
So, there's more to be done.
I would like to highlight here, but of course, I'm glad to see when the cash conversion is above 200%.
I would also like to highlight here the seasonal pattern, which we've mentioned many times now, but usually Q4 has the strongest cash flow. And then for the full year, we came in at 99% cash conversion, just below our target of 100%. The next slide, please. So the average interest rate here for the full year came in at 5.8%, down from 6.1% a year ago.
As I mentioned, we lowered the leverage here from 3.76 in Q3 down to 3.25. And after the rights issue, this leverage is set to go down below 2.5, which is in line with our long-term targets. I would also like to highlight here with the rights issue. We have an updated covenant level in 2026.
And we also have improved interest rate levels. On the interest rate levels, we also dropped down two steps from where we are today, down to where we will end up after the rights issue, meaning savings of roughly 20 million yearly, on just all else equal.
So to speak, on the interest rate levels. Remember, we had roughly 145 million in paid interest during 2025. With that said, we can move on to the next slide. Where we take a step back and look at how full year 2025 came in. So our net sales grew by 10.6% compared to our target of 5%. On the profitability side, we had a margin of 8.2% compared to the target of 10%. We were very close to meeting the target, coming in at 99%, as mentioned. And then on the capital structure side here before the rights issue, we came in at 3.25, which was, by the way, also in line with what the covenant level was.
Moving on please.
Then some words about the rights issue. So we today announced a fully guaranteed SEK 504 million rights issue. And, some words about the commitment or the undertakings. I would say that roughly 320 million came in from the large shareholders, Connecting Capital and Hauser, and also a large portion from our founder and chairman, Mikael Carlsson, took a large part of that. And then from the other board members and management, roughly 32 million came in, of which myself have an undertaking of 19 million. Key employees committed roughly 29 million, and 120 million came from other shareholders and investors.
So all in all, I'm very, very pleased by the commitment and the strength that we demonstrate with this. Remember also that no underwriter took any fee for this, which is a very strong signal.
Here is the background and motive regarding the rights issue. We are of course strengthening our balance sheet with this, as we've mentioned here.
And this also makes us able to grow in another way that we have historically been quite constrained by. So now with this, we have the possibility to do organic growth initiatives and selective acquisitions once again, which we are very, very glad to be able to do.
But remember here, we will not go on a shopping spree or anything like that; of course, we will do selective acquisitions.
Some key timeline here. Today, we've also announced an Extraordinary General Meeting, which is scheduled for March 6th. The subscription trading and subscription rights are due from the 16th to 25th of March, and the publication of the final subscription level is from the 1st of April.
Let's talk some more about the rights issue. Why do we do it now? I would say that we have a good momentum.
We are seeing two consecutive quarters with organic growth and a healthy order backlog also growing organically. We see all in all that the market signs are improving. And this gives us also room for growth when we need it, not when we have to.
So we do it in a pre-emptive strike.
And then on how we see acquisitions going forward. I mentioned that there will be selective regarding the UK turnaround. And BSR, as we've mentioned earlier, we still see a very strong demand in general for our services in the UK. And we also see that the BSR risk is somewhat lower in conjunction with the announcement we made in December. We also get an approval and improved financial agreement with the banks, which also assists here in the journey ahead.
Yes. Next slide, please. So some concluding remarks. 2025 was the year when we did the hard work. I would say we divested underperforming assets and improved cash flow in the second half. And we strengthened our organic growth and our backlog.
In general, I would say that we're entering 2026 as a leaner, more focused, and more financially robust company.
If you just have some highlights. Once again, remember that we had a strong organic growth of 5.1% in Q4. We saw improving margins both in Q4 and for the full year 2025. And I would say that we are ready for the market turn.
The organic order backlog was up 4.2% in Q4.
We are moving to below 2.5x leverage following the rights issue. We see the new capital coming in with very, very strong interest from shareholders, board members, key employees without any fees, as I mentioned. Then, moving back to this M&A agenda, we will be, of course, disciplined and selective.
So to sum it up, I would say that we are strengthening today to capture tomorrow's recovery. With that said, we thank you for your time and open up for questions.